Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs.

Schang, L M

Schang, L M.

Affiliation

Schang LM; 315C Heritage Medical Research Center. Edmonton, Alberta T6G 2S2, Canada. luis.schang@ualberta.ca

Curr Drug Targets Infect Disord ; 5(1): 29-37, 2005 Mar.

Article in En | MEDLINE | ID: mdl-15777196

Subject(s)

Antiviral Agents/administration & dosage; Cyclin-Dependent Kinases/antagonists & inhibitors; Drug Delivery Systems/methods; Protein Kinase Inhibitors/administration & dosage; Animals; Antiviral Agents/chemistry; Antiviral Agents/metabolism; Cyclin-Dependent Kinases/metabolism; Humans; Protein Kinase Inhibitors/chemistry; Protein Kinase Inhibitors/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Drug Delivery Systems / Cyclin-Dependent Kinases / Protein Kinase Inhibitors Limits: Animals / Humans Language: En Journal: Curr Drug Targets Infect Disord Journal subject: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Year: 2005 Document type: Article Affiliation country: Canada Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links